1. Home
  2. VMD vs EOLS Comparison

VMD vs EOLS Comparison

Compare VMD & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viemed Healthcare Inc.

VMD

Viemed Healthcare Inc.

HOLD

Current Price

$8.88

Market Cap

313.3M

Sector

N/A

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.39

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VMD
EOLS
Founded
2006
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
313.3M
284.3M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
VMD
EOLS
Price
$8.88
$6.39
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
238.8K
910.2K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
32.14
1.23
EPS
0.06
N/A
Revenue
$270,280,000.00
$297,176,000.00
Revenue This Year
$17.88
$13.27
Revenue Next Year
$14.98
$17.62
P/E Ratio
$153.00
N/A
Revenue Growth
20.52
11.61
52 Week Low
$5.93
$3.86
52 Week High
$10.18
$10.62

Technical Indicators

Market Signals
Indicator
VMD
EOLS
Relative Strength Index (RSI) 43.09 75.11
Support Level $8.62 $5.88
Resistance Level $10.04 $6.40
Average True Range (ATR) 0.40 0.36
MACD -0.12 0.14
Stochastic Oscillator 32.61 80.54

Price Performance

Historical Comparison
VMD
EOLS

About VMD Viemed Healthcare Inc.

Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: